COMP mutations: Domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes

Journal of Cellular Biochemistry

Volumn 103, Issue 3, 2008, Pages 778-787

  Chen, Tung Ling L ^a   Posey, Karen L ^b   Hecht, Jacqueline T ^b,c   Vertel, Barbara M ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Shriners Hospital for Children   (United States)

Author keywords

(MED); (PSACH); Chondrocyte; COMP; Endoplasmic reticulum; Multiple epiphyseal dysplasia; Pseudoachondroplasia

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARTILAGE CELL; CELL TRANSPORT; CHONDROSARCOMA; CONTROLLED STUDY; GENE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN;

ACHONDROPLASIA; AMINO ACID MOTIFS; ANIMALS; CARTILAGE; CELL MOVEMENT; CHONDROCYTES; DNA MUTATIONAL ANALYSIS; EXTRACELLULAR MATRIX PROTEINS; GENOTYPE; GLYCOPROTEINS; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION; OSTEOCHONDRODYSPLASIAS; PHENOTYPE; RATS;

RATTUS;

EID: 39049089695     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21445     Document Type: Article

References (37)

1. Adams JC. 2001. Thrombospondins: Multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 17:25-51.
2. Adams J, Tucker RP, Lawler J. 1995. The thrombospondin gene family. NY: Springer-Verlag.
3. Berg JM, Tymoczko JL, Stryer L. 2006. Biochemistry. New York: W.H. Freeman and Company.
4. Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, Leroy JG, Mortier GR, Rimoin DL, Lachman RS, Gaines ES, Cekleniak JA, Knowlton RG, Cohn DH. 1995. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 10:330-336.
5. Briggs MD, Mortier GR, Cole WG, King LM, Golik SS, Bonaventure J, Nuytinck L, De Paepe A, Leroy JG, Biesecker L, Lipson M, Wilcox WR, Lachman RS, Rimoin DL, Knowlton RG, Cohn DH. 1998. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet 62:311-319.
6. Budde B, Blumbach K, Ylostalo J, Zaucke F, Ehlen HW, Wagener R, Ala-Kokko L, Paulsson M, Bruckner P, Grassel S. 2005. Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Mol Cell Biol 25:10465-10478.
7. Carlson CB, Bernstein DA, Annis DS, Misenheimer TM, Hannah BL, Mosher DF, Keck JL. 2005. Structure of the calcium-rich signature domain of human thrombospondin-2. Nat Struct Mol Biol 12:910-914.
8. Chen TL, Stevens JW, Cole WG, Hecht JT, Vertel BM. 2004. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH. Matrix Biol 23:433-444.
9. Cooper RR, Ponseti IV, Maynard JA. 1973. Pseudoachondroplasia dwarfism. A rough-surfaced endoplasmic reticulum disorder. J Bone Joint Surg Am 55A:475-484.
10. Czarny-Ratajczak M, Lohiniva J, Rogala P, Kozlowski K, Perala M, Carter L, Spector TD, Kolodziej L, Seppanen U, Glazar R, Krolewski J, Latos-Bielenska A, Ala-Kokko L. 2001. A mutation in col9a1 causes multiple epiphyseal dysplasia: Further evidence for locus heterogeneity. Am J Hum Genet 69:969-980.
11. Deere M, Sanford T, Ferguson HL, Daniels K, Hecht JT. 1998. Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. Am J Med Genet 80:510-513.
12. Deere M, Sanford T, Francomano CA, Daniels K, Hecht JT. 1999. Identification of nine novel mutations in cartilage oligomeric matrix protein in patients with pseudoachondroplasia and multiple epiphyseal dysplasia. Am J Med Genet 85:486-490.
13. Delot E, Brodie SG, King LM, Wilcox WR, Cohn DH. 1998. Physiological and pathological secretion of cartilage oligomeric matrix protein by cells in culture. J Biol Chem 273:26692-26697.
14. DiCesare PE, Morgelin M, Mann K, Paulsson M. 1994. Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur J Biochem 223:927-937.
15. Hall JG. 1975. Pseudoachondroplasia. Birth Defects Orig Artic Ser 11:187-202.
16. Hecht JT, Nelson LD, Crowder E, Wang Y, Elder FF, Harrison WR, Francomano CA, Prange CK, Lennon GG, Deere M, Lawler J. 1995. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet 10:325-329.
17. Hecht JT, Deere M, Putnam E, Cole W, Vertel B, Chen H, Lawler J. 1998. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol 17:269-278.
18. Hecht JT, Hayes E, Snuggs M, Decker G, Montufar-Solis D, Doege K, Mwalle F, Poole R, Stevens J, Duke PJ. 2001. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes. Matrix Biol 20:251-262.
19. Hecht JT, Makitie O, Hayes E, Haynes R, Susie M, Montufar-Solis D, Duke PJ, Cole WG. 2004. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate. J Orthop Res 22:759-767.
20. Hecht JT, Hayes E, Haynes R, Cole WG. 2005. COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol 23:525-533.
21. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D. 1992. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267:6132-6136.
22. Ikegawa S, Ohashi H, Nishimura G, Kim KC, Sannohe A, Kimizuka M, Fukushima Y, Nagai T, Nakamura Y. 1998. Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Genet 103:633-638.
23. Kennedy J, Jackson G, Ramsden S, Taylor J, Newman W, Wright MJ, Donnai D, Elles R, Briggs MD. 2005a. COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia. Eur J Hum Genet 13:547-555.
24. Kennedy J, Jackson GC, Barker FS, Nundlall S, Bella J, Wright MJ, Mortier GR, Neas K, Thompson E, Elles R, Briggs MD. 2005b. Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia-multiple epiphyseal dysplasia disease group. Hum Mutat 25:593-594.
25. King KB, Kimura JH. 2003. The establishment and characterization of an immortal cell line with a stable chondrocytic phenotype. J Cell Biochem 89:992-1004.
26. Kvansakul M, Adams JC, Hohenester E. 2004. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. EMBO J 23:1223-1233.
27. McKeand J, Rotta J, Hecht JT. 1996. Natural history study of pseudoachondroplasia. Am J Med Genet 63:406-410.
28. Merritt TM, Alcorn JL, Haynes R, Hecht JT. 2006. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype. J Orthop Res 24:700-707.
29. Merritt TM, Bick R, Poindexter BJ, Alcorn JL, Hecht JT. 2007. Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes. Am J Pathol 170:293-300.
30. Newton G, Weremowicz S, Morton CC, Copeland NG, Gilbert DJ, Jenkins NA, Lawler J. 1994. Characterization of human and mouse cartilage oligomeric matrix protein. Genomics 24:435-439.
31. Oldberg A, Antonsson P, Lindblom K, Heinegard D. 1992. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 267:22346-22350.
32. Schmitz M, Becker A, Schmitz A, Weirich C, Paulsson M, Zaucke F, Dinser R. 2006. Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion. J Biol Chem 281:32587-32595.
33. Spranger JW, Brill PW, Poznanski AK. 2002. Bone dysplasias, 2nd edition. New York: Oxford University Press, Inc.
34. Superti-Furga A, Unger S, Society NGotISD. 2007. Nosology and Classification of Genetic Skeletal Disorders: 2006 Revision. Am J Med Genet 143:1-18.
35. Unger S, Hecht JT. 2001. Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments. Am J Med Genet 106:244-250.
36. Unger SL, Briggs MD, Holden P, Zabel B, Ala-Kokko L, Paassilta P, Lohiniva J, Rimoin DL, Lachman RS, Cohn DH. 2001. Multiple epiphyseal dysplasia: Radiographic abnormalities correlated with genotype. Pediatr Radiol 31:10-18.
37. Xu K, Zhang Y, Ilalov K, Carlson CS, Feng JQ, Di Cesare PE, Liu CJ. 2007. COMP associates with gep and potentiates gep-stimulated chondrocyte proliferation. J Biol Chem 282:11347-11355.